Shiny K. Kajal/LinkedIn
Mar 24, 2026, 02:55
Shiny K Kajal: FFP as a Targeted Coagulation Therapy
Shiny K. Kajal, Senior Resident at Adesh University, shared a post on LinkedIn:
”Post 27- FFP is not just ‘something to hang.’
It’s not a fluid.
It’s not a reflex.
It’s not routine.
It is targeted coagulation therapy.
If there’s no active bleeding or significant coagulopathy,
ask yourself – what exactly are you treating?
Because every unit carries risk:
TRALI. TACO. Allergic reactions. Infection.
More plasma ≠ better outcomes.
Correction ≠ clinical benefit.
Transfuse with purpose.
Dose appropriately.
Treat the patient – not the comfort of doing something.”

Shiny K. Kajal/LinkedIn
Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments